Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock

Journal of Leukocyte Biology

Volumn 77, Issue 5, 2005, Pages 729-738

  Martínez, Carmen ^a   Juarranz, Yasmina ^a   Abad, Catalina ^a   Arranz, Alicia ^a   Miguel, Begoña G ^a   Rosignoli, Florencia ^a   Leceta, Javier ^a   Gomariz, Rosa P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Endotoxin; Immunopeptides; Inflammation

Indexed keywords

AMYLOID A PROTEIN; FIBRINOGEN; G PROTEIN COUPLED RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PITUITARY ADENYLATE CYCLASE 1; PITUITARY ADENYLATE CYCLASE 1 RECEPTOR; PROTEIN VPAC1; PROTEIN VPAC2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAM NEGATIVE INFECTION; IMMUNOPATHOLOGY; IN VIVO STUDY; INTENSIVE CARE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SENSOR; SEPTIC SHOCK;

ACUTE-PHASE REACTION; ANIMALS; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE-1; INTESTINES; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE GROWTH FACTORS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; NEUTROPHIL INFILTRATION; NITRIC OXIDE; PEROXIDASE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, CELL SURFACE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SERUM AMYLOID A PROTEIN; SHOCK, SEPTIC; VASCULAR CELL ADHESION MOLECULE-1; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 18244374194     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0704432     Document Type: Article

References (56)

1. Alexandre, D., Vaudry, H., Grumolato, J., Turquier, V., Fournier, A., Jegou, S., Anouar, Y. (2002) Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance. Endocrinology 143, 2680-2692.
2. Delgado, M., Abad, C., Martinez, C., Leceta, J., Gomariz, R. P. (2001) Vasoactive intestinal peptide prevents experimental arthritis by down-regulating both autoimmune and inflammatory components of the disease. Nat. Med. 7, 563-568.
3. Abad, C., Martinez, C., Leceta, J., Gomariz, R. P., Delgado, M. (2001) Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy. J. Immunol. 167, 3182-3189.
4. Abad, C., Martinez, C., Juarranz, M. G., Arranz, A., Leceta, J., Delgado, M., Gomariz, R. P. (2003) Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterology 124, 961-971.
5. Delgado, M., Martinez, C., Pozo, D., Calvo, J. R., Leceta, J., Ganea, D., Gomariz, R. P. (1999) Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) protect mice from letal endotoxemia through the inhibition of TNF-α and IL-6. J. Immunol. 162, 1200-1205.
6. Gomariz, R. P., Martinez, C., Abad, C., Leceta, J., Delgado, M. (2001) Immunology of VIP: a review and therapeutical perspectives. Curr. Pharm. Des. 7, 89-111.
7. Riedemann, N. C., Guo, R. F., Ward, P. A. (2003) The enigma of sepsis. J. Clin. Invest. 112, 460-467.
8. Henninger, D. D., Panes, J., Eppihimer, M., Russell, J., Gerritsen, M., Anderson, D. C., Granger, D. N. (1997) Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J. Immunol. 158, 1825-1834.
9. Cowley, H. C., Heney, D., Gearing, A. J. H., Hemingway, L., Webster, N. R. (1994) Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit. Care Med. 22, 651-657.
10. Nakae, H., Endo, S., Yamada, Y., Inada, K. (2000) Bound and soluble adhesion molecule and cytokine levels in patients with severe burns. Burns 26, 139-144.
11. Nakae, H., Endo, S., Inada, K., Takakuwa, T., Kasai, T. (1996) Changes in adhesion molecule levels in sepsis. Res. Commun. Mol. Pathol. Pharmacol. 91, 329-338.
12. Heinrich, P. C., Castell, J. V., Andus, T. (1990) Interleukin-6 and acute phase response. Biochem. J. 265, 621-636.
13. Uhlar, C. M., Whitehead, A. S. (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501-523.
14. Kilbourn, R., Traber, D. L., Szabo, C. (1997) Nitric oxide and shock. Dis. Mon. 43, 277-348.
15. Thiemermann, C. (1997) Nitric oxide and septic shock. Gen. Pharmacol. 29, 159-166.
16. Delgado, M., Abad, C., Martinez, C., Juarranz, M. G., Arranz, A., Gomariz, R. P., Leceta, J. (2002) Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med. 80, 16-24.
17. Martinez, C., Abad, C., Delgado, M., Arranz, A., Juarranz, M. G., Rodríguez-Henche, N., Brabet, P., Leceta, J., Gomariz, R. P. (2002) Antiinflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Proc. Natl. Acad. Sci. USA 99, 1053-1058.
18. Jamen, F., Persson, K., Bertrand, C., Rodriguez-Henche, N., Puech, R., Bockaert, J., Ahren, B., Brabet, P. (2000) PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J. Clin. Invest. 105, 1307-1315.
19. Bradley, P. P., Priebat, D. A., Christensen, R. D., Rothstein, G. (1982) Cellular and extracellular mycloperoxidase in pyogenic inflammation. J. Invest. Dermatol. 78, 206-209.
20. Bustin, S. A. (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reactions assays. J. Mol. Endocrinol. 25, 169-193.
21. Green, L. C., Wagner, D. A., Glogowski, J. S., Skipper, P. L., Wishnok, J. S., Tannenbaum, S. R. (1982) Analysis of nitrate, nitrite anil [15-N]nitrite in biological fluids. Anal. Biochem. 126, 131-138.
22. Bligh, E. G., Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
23. Preiss, E., Loomis, C. R., Bell, R. M., Niedel, J. E. (1987) Quantitative measurement of sn-1,2 diacylglicerol. Methods Enzymol. 141, 294-300.
24. Gourlet, P., Vandermeers, A., Vandermeers-Piret, M. C., Rathe, J., De Neef, P., Christophe, J. (1995) Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Eur. J. Pharmacol. 287, 7-11.
25. Rawlings, S. R. (1994) PACAP, PACAP receptors, and intracellular signalling. Mol. Cell. Endocrinol. 101, C5-C9.
26. Zhang, F., Zhao, G., Dong, Z. (2001) Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide. Int. Immunopharmacol. 1, 1375-1384.
27. Lee, S. C., Han, J. S., Seo, J. K., Cha, Y. N. (2003) Modulation of cyclooxygenase-2 expression by phosphatidyleholine specific phospholipase C and D in macrophages stimulated with lipopolysaccharide. Mol. Cells 15, 320-326.
28. Nuytinck, J. K. S., Goris, R. J. A., Redl, H., Schlag, S. M., Zimmerman, G. A. (1986) Posttraumatic complications and inflammatory mediators. Arch. Surg. 121, 886-890.
29. Tan, Y. R., Qin, X. Q., Guan, C. X., Zhang, C. Q., Luo, Z. Q., Sun, X. H. (2003) Regulatory peptides modulate ICAM-1 gene expression and NF-κB activity in bronchial epithelial cells. Sheng Li Xue Bao 55, 121-127.
30. Sellati, T. J., Burns, M. J., Ficazzola, M. A., Furie, M. B. (1995) Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect. Immun. 63, 4439-4447.
31. Endo, S., Inada, K., Kasai, T., Takakuma, T., Yamada, Y., Koike, S., Wakabayashi, G., Niimi, M., Taniguchi, S., Yoshida, M. (1995-96) Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J. Inflamm. 46, 212-219.
32. Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., Van Hinsberg, V., Sozzani, S., Bussolino, F., Poli, V., Ciliberto, G., Mantovani, A. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6, 315-325.
33. Modur, V., Li, Y., Zimmerman, G. A., Prescott, S. M., Mc, M., Intyre, T. M. (1997) Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor α. J. Clin. Invest. 100, 2752-2756.
34. Fenton, R. R., Molesworth-Kenyon, S., Oakes. J. E., Lausch, R. N. (2002) Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Vis. Sci. 43, 737-743.
35. Biswas, P., Delfanti, F., Bernasconi, S., Mengozzi, M., Cota, M., Polentarutti, N., Mantovani, A., Lazzarin, A., Sozzani, S., Poli, G. (1998) Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91, 258-265.
36. Rijneveld, A. W., Van den Dobbelsteen, G. P., Florquin, S., Standiford, T. J., Speelman, P., Van Alphen, L., Van der Poll, T. (2002) Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J. Infect. Dis. 185, 123-126.
37. Caldenhoven, E., Coffer, P., Yuan. J., Van de Stolpe, A., Horn, F., Kruijer, W., Van der Saag, P. T. (1994) Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-γ involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 269, 21146-21154.
38. + channels in endothelial cells. J. Pharmacol. Exp. Ther. 276, 690-696.
39. Groneberg, D. A., Hartmann, P., Dinh, Q. T., Fischer, A. (2001) Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways. Lab. Invest. 81, 749-755.
40. Geiger, T., Andus, T., Klapproth, J., Hirano, T. Kishimoto, T., Heinrich, P. C. (1988) Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 18, 717-721.
41. Ray, A. (2000) A SAF binding site in the promoter region of human γ-fibrinogen gene functions as an IL-6 response element. J. Immunol. 165, 3411-3417.
42. Guijarro, L. G., Rodriguez-Henche, N., Garcia-Lopez, E., Nogerales, F., Dapena, M. A., Juarranz, M. G., Prieto, J. C. (1995) Receptors for pituitary adenylate cyclase-activating peptide in human liver. J. Clin. Endocrinol. Metab. 80, 2451-2457.
43. Robberecht, P., Gourlet, P., Cauvin, A., Buscail, L., De Neef, P., Arimura, A., Christophe, J. (1991) PACAP and VIP receptors in rat liver mentbranes. Am. J. Physiol. 260, G97-G102.
44. Jensen, L. E., Whitehead, A. S. (1998) Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334, 489-503.
45. Steel, D. M., Whitehead, A. S. (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15, 81-88.
46. Fratelli, M., Zinetti, M., Fantuzzi, G., Spina, C., Napoletano, G., Donatiello, G., Ravagnan, R., Sipa, J. D., Casey, C. A., Ghezzi, P. (1997) Time course of circulating acute phase proteins and cytokines in septic patients. Amyloid. 4, 33-97.
47. Morris, S. M., Billiar, T. R. (1994) New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266, E829-E839.
48. Nathan, G. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
49. Titheradge, M. A. (1999) Nitric oxide in septic shock. Biochim. Biophys. Acta 1411, 437-455.
50. Delgado, M., Muñoz-Elias, E. J., Gomariz, R. P., Ganea, D. (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-κB and IFN regulatory factor I activation. J. Immunol. 162, 4685-4696.
51. Delgado, M., Muñoz-Elias, E. J., Kan, Y., Gozes, I., Fridkin, M., Breuneman, D. E., Gomariz, R. P., Ganea, D. (1998) Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit TNFα transcriptional activation by regulating NF-κB and CREB/c-Jun. J. Biol. Chem. 273, 31427-31437.
52. Ganea, D., Sun, L. (1993) VIP downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes. J. Neuroimmunol. 47, 147-158.
53. Tatsuno, I., Gottschall, P. E., Arimura, A. (1991) Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase-activating polypeptide: a comparative study with vasoactive intestinal peptide. Endocrinology 128, 728-734.
54. De la Fuente, M., Delgado, M., Del Río, M., Martínez, C., Hernanz, A., Gomariz, R. P. (1993) Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function of rat macrophages. Protein kinase C involvement. Regul. Pept. 48, 345-353.
55. Delgado, M., Garrido, E., De la Fuente, M., Gomariz, R. P. (1996) Pituitary adenylate cyclase-activating polypeptide (PACAP38) stimulates rat peritoneal macrophages functions. Peptides 17, 1097-1105.
56. Martínez, C., Delgado, M. Pozo, D. Leceta, J., Calvo, J. R., Ganea, D., Gomariz, R. P. (1998) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J. Leukoc. Biol. 63, 591-601.